Quality of Clinical Trials
Evidence-based medicine attempts to objectively evaluate the quality of clinical research by critically assessing techniques reported by researchers in their publications.
- Trial design considerations. High-quality studies have clearly defined eligibility criteria and have minimal missing data.
- Generalizability considerations. Studies may only be applicable to narrowly defined patient populations and may not be generalizable to other clinical contexts.
- Follow-up. Sufficient time for defined outcomes to occur can influence the study outcomes and the statistical power of a study to detect differences between a treatment and control arm.
- Power. A mathematical calculation can determine if the number of patients is sufficient to detect a difference between treatment arms. A negative study may reflect a lack of benefit, or simply a lack of sufficient quantities of patients to detect a difference.
Read more about this topic: Evidence-based Medicine
Famous quotes containing the words quality of, quality and/or trials:
“The quality of the will to power is, precisely, growth. Achievement is its cancellation. To be, the will to power must increase with each fulfillment, making the fulfillment only a step to a further one. The vaster the power gained the vaster the appetite for more.”
—Ursula K. Le Guin (b. 1929)
“A good essay must have this permanent quality about it; it must draw its curtain round us, but it must be a curtain that shuts us in, not out.”
—Virginia Woolf (1882–1941)
“Old age is not a disease—it is strength and survivorship, triumph over all kinds of vicissitudes and disappointments, trials and illnesses.”
—Maggie Kuhn (b. 1905)